Hans-Peter Hasler is a Swiss businessperson who founded Vicarius Pharma AG and who has been the head of 7 different companies. Presently, Mr. Hasler holds the position of Non-Executive Chairman for Shield Therapeutics Plc, Chairman for Medical Imaging Analysis Center and Chairman at HBM Healthcare Investments AG. Mr. Hasler is also on the board of Minerva Neurosciences, Inc., Dr. Reddy's Laboratories SA, Vicarius Pharma AG (former Chief Executive Officer & Director) and Gain Therapeutics, Inc. and Principal at Hph Management GmbH.
In his past career he was Managing Director at Wyeth-lederle Pharma GmbH, Chief Operating Officer & Executive Vice President for Biogen, Inc. Chief Operating Officer for Biogen Idec, Inc. (North Carolina) and Executive Vice President-International at Biogen MA, Inc. (both are subsidiaries of Biogen, Inc.), Managing Director at Wyeth Pharma GmbH, Managing Director at Wyeth Pharmaceuticals AG, Chief Operating Officer at Elan Corp. Plc, Chief Marketing Officer at Wyeth Corp. and Head-Global Strategic Marketing at Wyeth Pharmaceuticals LLC.
He received an undergraduate degree from Schweizerisches Institut für Betriebsökonomie AG.